ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2023 and some content may be unavailable. To unlock all content for 2023, please visit the archives.

Abstract: FR-PO1018

Urinary Phosphate Contributes to Kidney Injury, Cyst Formation, and Inflammation

Session Information

Category: CKD (Non-Dialysis)

  • 2303 CKD (Non-Dialysis): Mechanisms

Authors

  • Jansson, Kyle, The University of Kansas Medical Center, Kansas City, Kansas, United States
  • Fields, Timothy A., The University of Kansas Medical Center, Kansas City, Kansas, United States
  • Stubbs, Jason R., The University of Kansas Medical Center, Kansas City, Kansas, United States
Background

High dietary phosphate intake increases urinary phosphate excretion and has been associated with an increased risk for chronic kidney disease (CKD) progression. We hypothesize that high dietary phosphate hastens CKD progression by stimulating tubular nanocrystal formation, epithelial cell injury, microcyst formation, and inflammation when concentrations of phosphate exceed supersaturation in tubular fluid; however, the mechanisms driving this relationship remain poorly defined.

Methods

First, a mouse model of cystic kidney disease, the Pkd1RC/RC mouse, was fed a high versus low phosphate diet and analyzed for changes in kidney cyst growth, mineral deposition, tubular injury, inflammation, and fibrosis. Second, NaPi2a-/- mice, a model of primary urinary phosphate wasting, was evaluated to determine the direct effect of urinary phosphate excretion on mechanisms of kidney injury and inflammation.

Results

Pkd1RC/RC mice fed a high phosphate diet exhibited more rapid cyst growth and increased deposition of phosphate-based crystals in their kidneys compared to mice fed a low phosphate diet. Mineral deposits in these kidneys were spatially colocalized with macrophages and osteopontin, a matricellular protein that is critical for maintaining urinary phosphate solubility. Moreover, gene expression for markers of kidney injury, inflammation, and fibrosis were increased in Pkd1RC/RC mice on a high phosphate diet. In separate studies utilizing NaPi2a-/- mice, phosphaturic mutants exhibited extensive kidney crystal deposition, reduced kidney function, as well as increased gene expression for markers of kidney injury, inflammation, and fibrosis compared to wild-type controls. Separate analysis of electron microscopy in wild type mice on a high phosphate diet showed interaction of phagocytic cells with kidney mineral deposits.

Conclusion

Increased urinary phosphate excretion directly contributes to tubular injury, kidney cyst growth, inflammation, and fibrosis in CKD. Current evidence suggests a direct interaction between phosphate-based nanocrystals and local inflammatory cells may be a primary contributor to this relationship.

Funding

  • NIDDK Support